Andrew Schorr interviews another very well know CLL specialist, Prof Dr. Michael Halleck
"Could monoclonal antibodies replace chemotherapy in treating CLL? Phase III clinical trials for these therapies are showing excellent results--especially in elderly patients--and may lead to chemo-free treatments that manage the disease with very few side effects. In this video, Dr. Michael Hallek from the Center for Integrated Oncology at the Universities of Cologne and Bonn in Germany, shares which patients are benefitting most from new approaches. "
Neil
Zanubrutinib vs. Ibrutinib Patient Power Video by Dr. Jennifer Brown MD PHD
